This suggests that pharmacological manipulation of pathways that normally converge onto FOXO3 to regulate stress response may restore the homeostasis of the ß-catenin-FOXO3 complex and promote neuronal compensation in HD. This evidence concerns the gene FOXO3 and Huntington disease.